Cost-Effectiveness Analysis of Etanercept in Combination with Methotrexate for Rheumatoid Arthritis - Markov Model Based on Data from Serbia

Data publikacji: 29 gru 2017

Zakres stron: 343 - 347

Otrzymano: 05 lip 2016

Przyjęty: 28 lip 2016

DOI: https://doi.org/10.1515/sjecr-2016-0070

Słowa kluczowe

rheumatoid arthritis, biological therapy, etanercept, cost-effectiveness analysis

© 2017 Marina Kostic, published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.